SCHEMBL450190

SCHEMBL450190

OC[CH]CCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL149819 0.82
SCHEMBL471953 0.77
SCHEMBL6387994 0.74
SCHEMBL428796 0.72 LMNA (0.38)
SCHEMBL105133 0.71
SCHEMBL491157 0.69
SCHEMBL3511006 0.69
SCHEMBL1828351 0.69
SCHEMBL735965 0.69
SCHEMBL8198407 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 382 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11325886-B2 Amide compounds, pharmaceutical compositions thereof, and methods of using the same OREGON HEALTH & SCIENCE UNIVERSITY (US) 2022-05-10 US claimed
CN-114437554-A Industrial oil sludge and preparation method thereof 上海藤轲汽车技术有限公司 2022-05-06 CN claimed
US-20210284599-A1 AMIDE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME OREGON HEALTH & SCIENCE UNIVERSITY (US) 2021-09-16 US claimed
CN-109732038-B Die-casting release agent and preparation method thereof 宁波辉宏新材料有限公司 2021-04-06 CN claimed
EP-3497077-A1 AMIDE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME Oregon Health & Science University (US) 2019-06-19 EP claimed
CN-109843849-A Amide compounds, pharmaceutical compositions thereof, and methods of use thereof 俄勒冈健康科学大学 2019-06-04 CN claimed
WO-2018032012-A1 AMIDE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME OREGON HEALTH & SCIENCE UNIVERSITY (US) 2018-02-15 WO claimed
CN-104173321-B The method for preparing pharmaceutical composition being administered by external use plaster, with anti-inflammatory analgesic activity, and the composition obtained with this 阿尔特根有限公司 2017-10-31 CN claimed
CN-103435569-A Novel salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents FERROKIN BIOSCIENCES INC 2013-12-11 CN claimed
CN-102149700-A Novel salts and polymorphs of desazadesferrothiocin polyether analogues as metal chelation agents FERROKIN BIOSCIENCES INC 2011-08-10 CN claimed
US-7053031-B2 Cleaning agents for the outer surfaces of means of transport CLARIANT GMBH (DE) 2006-05-30 US claimed
US-20050203094-A1 2-[5-(5-carbamimidoyl-1h-heteroaryl)]-6-hydroxybiphenyl-3-yl derivatives as factor viia inhibitors AXYS PHARMACEUTICALS, INC. 2005-09-15 US claimed
US-20050107408-A1 Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones ROCHE PALO ALTO LLC 2005-05-19 US claimed
US-20050003558-A1 Biological sample component purification and differential display CHIRON CORPORATION (US) 2005-01-06 US claimed
EP-1474400-A1 2-[5-(5-CARBAMIMIDOYL-1H-HETEROARYL)] -6-HYDROXYBIPHENYL-3-YL DERIVATIVES AS FACTOR VIIA INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2004-11-10 EP claimed
US-6783929-B1 COMPRISES POLYAMIDE LIGANDS FOR ENHANCED EFFICIENCY OF PROTEOMICS CHIRON CORPORATION 2004-08-31 US claimed
WO-2003068756-A1 2-[5-(5-CARBAMIMIDOYL-1H-HETEROARYL)]-6-HYDROXYBIPHENYL-3-YL DERIVATIVES AS FACTOR VIIA INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2003-08-21 WO claimed
EP-1155327-A1 BIOLOGICAL SAMPLE COMPONENT PURIFICATION AND DIFFERENTIAL DISPLAY CHIRON CORPORATION (US) 2001-11-21 EP claimed
WO-2001033230-A2 BIOLOGICAL SAMPLE COMPONENT PURIFICATION AND DIFFERENTIAL DISPLAY CHIRON CORPORATION (US) 2001-05-10 WO claimed
EP-0284174-B1 THERAPEUTIC PREPARATIONS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1992-07-29 EP claimed